Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fanping Meng and Jun-Liang Fu.
Fanping Meng
Connection Strength
0.339
Jun-Liang Fu
  1. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020 08 27; 5(1):172.
    View in: PubMed
    Score: 0.225
  2. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021 02 10; 6(1):58.
    View in: PubMed
    Score: 0.058
  3. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020 08 04; 32(2):188-202.e5.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.